Literature DB >> 16495252

Rate of elimination of Wolbachia pipientis by doxycycline in vitro increases following drug withdrawal.

Benjamin L Makepeace1, Lisa Rodgers, Alexander J Trees.   

Abstract

Wolbachia pipientis is an obligate intracellular bacterium within the family Anaplasmataceae that infects many terrestrial arthropods and arthropod-transmitted nematodes (filariae). Several filarial species are major human pathogens, and antibiotics with activity against Wolbachia offer a promising new therapeutic approach, since the adult worms are relatively refractory to conventional anthelmintics but depend on Wolbachia for reproduction and viability. In a natural filarial parasite of cattle, Onchocerca ochengi, intermittent chemotherapy is adulticidal whereas the equivalent dose administered as a continuous treatment is not. To investigate this further and to aid the design of efficacious regimens for human therapy, we used Wolbachia-infected Aedes albopictus mosquito cells in vitro. Here, we describe for the first time the accelerated depletion of bacteria after antibiotic withdrawal relative to the rate of elimination in the continuous presence of the drug. Mosquito cells were incubated with doxycycline while changes in 16S (bacterial) and 18S (host) rRNA and rRNA genes were determined by quantitative PCR assays. In cultures treated for 7 or 14 days followed by 7 days of drug withdrawal, the Wolbachia-to-Aedes rRNA ratio declined by approximately 6 log, whereas immediately after 14 or 21 days of continuous treatment, the reduction was only approximately 4 log (P < 0.05). However, low levels of 16S rRNA remained after 21 days of treatment, irrespective of whether doxycycline was withdrawn. Application of similar methodology to related intracellular bacteria may reveal that this posttreatment effect is not restricted to Wolbachia and could have wider implications for the design of intermittent regimens for antibiotic chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495252      PMCID: PMC1426454          DOI: 10.1128/AAC.50.3.922-927.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

1.  Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.

Authors:  A Hoerauf; S Mand; O Adjei; B Fleischer; D W Büttner
Journal:  Lancet       Date:  2001-05-05       Impact factor: 79.321

2.  Development and transfection of short-term primary cell cultures from Brugia malayi.

Authors:  Tarig B Higazi; Limin Shu; Thomas R Unnasch
Journal:  Mol Biochem Parasitol       Date:  2004-10       Impact factor: 1.759

3.  Nucleotide sequence of a mosquito 18S ribosomal RNA gene.

Authors:  G D Baldridge; A M Fallon
Journal:  Biochim Biophys Acta       Date:  1991-07-23

Review 4.  Degradation of stable RNA in bacteria.

Authors:  Murray P Deutscher
Journal:  J Biol Chem       Date:  2003-08-26       Impact factor: 5.157

5.  In vitro cultivation of Wolbachia pipientis in an Aedes albopictus cell line.

Authors:  S L O'Neill; M M Pettigrew; S P Sinkins; H R Braig; T G Andreadis; R B Tesh
Journal:  Insect Mol Biol       Date:  1997-02       Impact factor: 3.585

6.  Pharmacokinetics of oxytetracycline in young cattle: comparison of conventional vs long-acting formulations.

Authors:  P L Toutain; J P Raynaud
Journal:  Am J Vet Res       Date:  1983-07       Impact factor: 1.156

Review 7.  Immunity to Onchocerca spp. in animal hosts.

Authors:  David Abraham; Richard Lucius; Alexander J Trees
Journal:  Trends Parasitol       Date:  2002-04

8.  Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi.

Authors:  S Townson; D Hutton; J Siemienska; L Hollick; T Scanlon; S K Tagboto; M J Taylor
Journal:  Ann Trop Med Parasitol       Date:  2000-12

9.  Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms?

Authors:  Tobias Hampshire; Shamit Soneji; Joanna Bacon; Brian W James; Jason Hinds; Ken Laing; Richard A Stabler; Philip D Marsh; Philip D Butcher
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

10.  In vitro effects of antibiotics on Brugia malayi worm survival and reproduction.

Authors:  R Rao; Gary J Well
Journal:  J Parasitol       Date:  2002-06       Impact factor: 1.276

View more
  14 in total

1.  Wolbachia in filarial parasites: targets for filarial infection and disease control.

Authors:  Kelly L Johnston; Mark J Taylor
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

2.  Detection of Wolbachia bacteria in multiple organs and feces of the triatomine insect Rhodnius pallescens (Hemiptera, Reduviidae).

Authors:  C I Espino; T Gómez; G González; M F Brazil do Santos; J Solano; O Sousa; N Moreno; D Windsor; A Ying; S Vilchez; A Osuna
Journal:  Appl Environ Microbiol       Date:  2008-11-21       Impact factor: 4.792

3.  Isolation and Propagation of Laboratory Strains and a Novel Flea-Derived Field Strain of Wolbachia in Tick Cell Lines.

Authors:  Jing Jing Khoo; Timothy J Kurtti; Nurul Aini Husin; Alexandra Beliavskaia; Fang Shiang Lim; Mulya Mustika Sari Zulkifli; Alaa M Al-Khafaji; Catherine Hartley; Alistair C Darby; Grant L Hughes; Sazaly AbuBakar; Benjamin L Makepeace; Lesley Bell-Sakyi
Journal:  Microorganisms       Date:  2020-07-01

4.  Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo.

Authors:  Andrea Schiefer; Alexander Schmitz; Till F Schäberle; Sabine Specht; Christine Lämmer; Kelly L Johnston; Dmitry G Vassylyev; Gabriele M König; Achim Hoerauf; Kenneth Pfarr
Journal:  J Infect Dis       Date:  2012-05-14       Impact factor: 5.226

5.  Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.

Authors:  Kelly L Johnston; Bo Wu; Ana Guimarães; Louise Ford; Barton E Slatko; Mark J Taylor
Journal:  Parasit Vectors       Date:  2010-10-14       Impact factor: 3.876

6.  A worm's best friend: recruitment of neutrophils by Wolbachia confounds eosinophil degranulation against the filarial nematode Onchocerca ochengi.

Authors:  Rowena D E Hansen; Alexander J Trees; Germanus S Bah; Udo Hetzel; Coralie Martin; Odile Bain; Vincent N Tanya; Benjamin L Makepeace
Journal:  Proc Biol Sci       Date:  2010-12-22       Impact factor: 5.349

7.  Integrated transcriptomic and proteomic analysis of the global response of Wolbachia to doxycycline-induced stress.

Authors:  Alistair C Darby; A Christina Gill; Stuart D Armstrong; Catherine S Hartley; Dong Xia; Jonathan M Wastling; Benjamin L Makepeace
Journal:  ISME J       Date:  2013-10-24       Impact factor: 10.302

8.  Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis.

Authors:  Kelly L Johnston; Louise Ford; Indira Umareddy; Simon Townson; Sabine Specht; Kenneth Pfarr; Achim Hoerauf; Ralf Altmeyer; Mark J Taylor
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-09-16       Impact factor: 4.077

9.  Wolbachia endosymbionts induce neutrophil extracellular trap formation in human onchocerciasis.

Authors:  Francesca Tamarozzi; Joseph D Turner; Nicolas Pionnier; Angela Midgley; Ana F Guimaraes; Kelly L Johnston; Steven W Edwards; Mark J Taylor
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

10.  Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.

Authors:  Ghaith Aljayyoussi; Hayley E Tyrer; Louise Ford; Hanna Sjoberg; Nicolas Pionnier; David Waterhouse; Jill Davies; Joanne Gamble; Haelly Metuge; Darren A N Cook; Andrew Steven; Raman Sharma; Ana F Guimaraes; Rachel H Clare; Andrew Cassidy; Kelly L Johnston; Laura Myhill; Laura Hayward; Samuel Wanji; Joseph D Turner; Mark J Taylor; Stephen A Ward
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.